Vera Rosenthal, a health communications specialist at the Food and Drug Administration, woke up to an email April 1 informing her that she had been affected by the Trump administration’s ...

The Food and Drug Administration on Monday urged patients and doctors to check that their Ozempic prescriptions are legitimate after the agency seized several hundred units of fake versions of ...

Argenx (ARGX) announced that the U.S. Food and Drug Administration approved a new option for patients to self-inject VYVGART Hytrulo with a prefilled syringe for the treatment of adult patients ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed. Recent ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to ...

This week, Brian King, the imperious former head of the FDA’s Center for Tobacco Products (CTP), was unceremoniously cashiered from his post and offered a demotion to a regional government office in ...

The U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products has had a change of leadership. The change was overdue. Even though he probably had some good intentions, Dr. Brian King ...

He covers federal public health agencies. Some of the Food and Drug Administration's efforts to support testing for the ongoing bird flu outbreak have been disrupted due to steep layoffs at the ...

The FDA’s Center for Tobacco Products (CTP) Director Brian King has been placed on administrative leave, and dozens of employees at the FDA’s CTP have been dismissed, including two entire ...

The US Food and Drug Administration was supposed to make a final decision about whether or not to approve Novavax's (NVAX) COVID-19 vaccine this week, but that deadline has passed with no clarity ...

Novartis (NVS) “announced the FDA has granted accelerated approval for Vanrafia, or atrasentan, a potent and selective endothelin A receptor antagonist, for the reduction of proteinuria in ...